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EXECUTIVE SUMMARY
It is estimated that Maine’s 39 hospitals produce approximately
111 tons of non-pathological, non-chemical, biomedical waste each
month. Most hospitals in the state have managed their biomedical
waste by contracting with private firms for disposal service, including transportation of the waste to out-of-state facilities for treatment
at an estimated statewide average cost of $685 per ton. Recently,
consolidation in the waste management industry and the closure of
some out-of-state incinerators have prompted the hospital industry
and environmental regulators to explore alternative waste-disposal
options. The cost effectiveness of utilizing current treatment technologies to sanitize, disinfect, shred, and dispose of biomedical waste
within the state is examined in relation to the costs of current
disposal practices in Maine.
The study employs a linear programming model to determine
the combination of treatment facilities, transportation options, and
disposal sites to treat all waste produced in Maine at the lowest
statewide cost. A least-cost solution is developed for three different
scenarios. The first two scenarios assume that all treated waste
must be shredded in accordance with current regulatory requirements. The third scenario assumes that regulations are changed to
require only that the sharps portion of the biomedical waste stream
be shredded. All scenarios assume that the treatment facilities
would be located on-site at one or more hospital locations, that there
are no barriers to inter-hospital shipment of waste for treatment,
and that any hospital has the option to continue shipping its waste
out of state.
In the first scenario, all hospitals are included as potential
locations for a waste-treatment facility in determining a shared,
least-cost solution. The lowest cost arrangement under these conditions includes two facilities, located in Bangor and Portland, to treat
95% of the total waste stream at a statewide average cost of $445 per
ton. The remaining 5% of the waste would continue to be shipped out
of state.
The second scenario assumes that four of the larger hospitals in
the state would seek to minimize their own costs separately.
Therefore these hospitals are not evaluated jointly with the other
hospitals in the state. The least-cost option for the remaining 35
hospitals is a treatment facility in Lewiston. (An additional machine
would be located in Bangor to minimize that hospital’s own-waste
treatment costs.) The total statewide cost of this scenario, including
the disposal costs incurred by the four larger hospitals, is $518 per
ton.
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The third scenario includes all hospitals as potential treatment
sites but excludes the shredding requirement for the non-sharps
portion of the waste stream. The reduced capital cost without
shredding leads to a solution with ten different treatment locations
at a total statewide average cost of $412 per ton.
Recommendations for additional research include an evaluation
of alternative waste-handling technologies, an examination of specific treatment technologies, and an analysis of off-site versus on-site
locations of treatment facilities.
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INTRODUCTION
Biomedical waste is defined as “wastes that may contain human
pathogens of sufficient virulence and in sufficient concentrations
that exposure to them by a susceptible host could result in disease”
(Maine DEP 1991:2). Historically, disposal of these wastes has been
by means of incineration. With tightening environmental regulations, this approach is no longer practical in Maine. The small
remaining volume of biomedical waste that is incinerated in Maine
is likely to be phased out soon. Currently, most Maine hospitals
contract with out-of-state waste-disposal firms for shipment to outof-state treatment facilities. With research indicating that byproducts of incineration include dioxin, lead, and mercury, with
growing concern about the cost and availability of out-of-state
disposal, and with the prospect of potential cost savings, there is a
growing interest in investigating alternative waste-disposal options
in Maine. This paper presents the results of a study to determine the
least-cost options for the collection, treatment, and disposal of
biomedical waste for Maine hospitals.
The analysis employs a mixed-integer linear programming
model that includes 39 hospitals as the sources of waste and as
potential sites for processing the waste (sterilizing and shredding),
six landfills potentially used for disposal of treated wastes, and up to
four different sizes of treatment equipment (see Figure 1).
The model accounts for shipments of biomedical waste between
hospitals while allowing hospitals to treat their own waste on-site if
it is cost-effective to do so. This allows the model to designate any
hospital as a generator of wastes, as a treatment site for wastes
generated at other hospitals, or as both. As depicted in Figure 2,
hospitals have the option to continue their current practice of
shipping raw (untreated) waste out of state, or shipping their raw
waste to a hospital that has the equipment and capacity to treat the
waste. Alternatively, hospitals may opt to purchase and install
equipment on-site for treatment of their own waste and/or waste
from other hospitals. All waste treated in-state is designated for
disposal at any of six different landfills included in the study as
potential disposal sites. Three different scenarios are examined
wherein the model identifies the optimal number, size, and location
of treatment facilities to minimize total waste-disposal costs given
the sources and volumes of waste and the distance to available
landfills.
Under the base scenario, all Maine hospitals are considered as
waste generators and potential waste-treatment sites. The model
determines the least-cost solution for all of the hospitals as a group.
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Figure 1. Locations of the 39 hospitals and six landfills included in the
study.
The second scenario, (referred to as the “big four scenario”) assumes
that the four hospitals that generate the most waste would (or will)
develop their own individual waste-management solutions separately from the other hospitals in the state. The model then
determines the least-cost solution for the remaining 35 hospitals as
a group. The third scenario is the “no-shred scenario” in which all
hospitals are considered waste generators and potential treatment
sites, but the shredding of the non-sharps portion of the waste
stream is not required. The biomedical sharps (for example, needles
and scalpels) are collected, treated, shredded, and disposed of
separately from the rest of the biomedical waste stream. In all
scenarios, shipping waste out of state, as is currently done, is
considered an option for each of the 39 hospitals.
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Medical Waste Management Model
Biomedical Waste Treatment and Disposal Options
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Figure 2. Alternative waste-management options included in the
study.
While it is important to note what this analysis can do, it is also
important to note its limitations. First, this analysis does not
attempt to determine least-cost options for individual hospitals in
Maine. Rather, this project evaluates least-cost options for all Maine
hospitals as a group. In addition, the costs of purchasing and
operating the equipment used in this analysis were derived from
averaging data obtained from commercial vendors. Last, by aggregating the cost estimates from equipment vendors, this project does
not attempt to promote any specific waste-processing technology;
the actual technology used by any group of hospitals is left for the
specific hospitals to determine. Thus, while this project attempts to
promote relative options, it does not make any claims to specific data
or technology.

BACKGROUND
Maine hospitals have made advances in recent years in reducing
the amount of waste they generate and the means by which that
waste is disposed. Through comprehensive education and awareness
programs, Maine hospitals are now segregating their waste. Solid
wastes are disposed of directly, recyclables are shipped to a recycling
facility, and the remaining 15%, which is biomedical waste, is
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disposed of separately (Health Care Without Harm 2000:3). Of the
15% that is biomedical waste, approximately one-seventh is pathological waste consisting of human tissues, organs and body parts.
Another small portion of the biomedical waste stream is comprised
of trace chemotherapy wastes that are chemical in nature and not
biological. Incineration remains the most appropriate means of
disposal for these latter two segments of the biomedical waste
stream.
Until recently, Maine hospitals had the option of selecting from
among several competing firms that offered biomedical wastedisposal services. Today, however, there is only one. Historically,
that waste-disposal firm collected biomedical waste from Maine
hospitals for shipment to an incinerator in Massachusetts. For
various reasons, the Massachusetts incinerator recently was shut
down permanently and the waste must now be shipped further south
for processing. While this is acceptable in the short term, higher
costs and uncertain availability make this option undesirable as a
long-term solution.
Under the current situation, biomedical waste disposal is contracted for a period of years with the existing waste disposal firm.
Because there is only one firm in operation, there is concern
regarding long-term competitive prices. Also, with the firm’s need to
ship the waste further south for treatment, disposal costs likely will
increase. In addition, there is no guarantee how long these southern
treatment sites will be in operation. As a result, Maine hospitals may
have to develop their own treatment and disposal solution.
The solution for Maine’s hospitals will be influenced by the
treatment equipment that is available. At present, there are two
fundamental technologies for the treatment of biomedical waste.
One technology uses steam/autoclave technology to kill all biological
life exposing the waste for 30-minutes to high-temperature steam
and pressure. The other uses microwave technology to disinfect the
waste, by bombarding the waste with microwaves for 25 minutes.
Both technologies are able to include a shredding component to their
operation. Six different models are evaluated with capacities ranging
from 6 to 130 tons per month.

THE MODEL
In an attempt to address the issue of biomedical waste-disposal
in Maine, the Maine Department of Environmental Protection
(DEP) contracted with The University of Maine’s Department of
Resource Economics and Policy (REP) to develop least-cost solutions
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for each of the three scenarios outlined in the Introduction. The
mixed-integer linear programming model used for this analysis
accomplishes its goal by employing cost estimates for the different
aspects of the collection, treatment, and disposal of biomedical waste
and arrives at the solution that generates the least cost for Maine
hospitals as a group. The individual costs included in this analysis
are associated with each aspect of the collection, treatment, and
disposal of the biomedical waste (see Table 1).

Collection Costs

The costs associated with the collection of biomedical waste
include bags into which the waste is placed, boxes into which the bags
are placed, the labor cost of boxing the bagged waste, and the cost of
shipping the boxed waste to the treatment site. These costs are
implicit in the current out-of-state disposal contracts. For those
hospitals that are treatment sites, on-site boxing of waste is unnecessary, so the cost of boxes and the cost of boxing the waste are
omitted. The cost of bags is still included because all waste must be
bagged. As for shipping the untreated waste, mileage and travel
times between hospitals are estimated, as are truck costs. From
these estimates a cost per ton-mile is determined from which a total
cost of shipping untreated waste from a generating hospital to a
treatment site is calculated for all possible shipping and receiving
combinations.

Treatment Costs

The costs associated with each treatment option consist of the
capital cost of acquiring the treatment equipment and the operating
and maintenance cost associated with the equipment1 . Cost estimates for the different equipment sizes of each treatment option
were obtained from the equipment vendors. Four treatment machine sizes were used for this analysis—a small (6 tons/month), a
medium (35 tons/month), a large (100 tons/month), and a very large
(130 tons/month). For graphical purposes, costs from these four
treatment machine sizes, along with interpolated values, are included
in Figure 3.
This cost curve reflects the treatment cost reduction possible as
larger quantities of waste are processed. If a hospital generates five
tons of biomedical waste per month and treats it with its own small
machine (i.e., 6-ton-per-month capacity), the average total cost for
The costs include a permitting fee established and collected by the Maine
DEP. The initial permitting fee is $3,500 per site. Thereafter, there is an
annual permitting of $1,000 per site.

1
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Collection, treatment, and disposal costs included in the
study.
cost ($)

Unit

Collection
Bags, Liner
Bags, All Other
Boxes, 4.5 Cu. Ft.
Loading*
Shipping**

0.20
0.50
1.25
100
0.66

per bag
per box
per box
per ton
per ton-mile

Disposal
Hauling****
Transfer*****

0.17
3.54

per ton-mile
per ton

Sharps Shredder
Capital
Operating & maintenance
Permitting Fees
Initial Fee
Annual Fee
Treatment
6 Ton, Capital***
6 Ton, O&M
35 Ton, Capital***
35 Ton, O&M
50 Ton, Capital***
50 Ton, O&M
94 Ton, Capital***
94 Ton, O&M
100 Ton, Capital***
100 Ton, O&M
130 Ton, Capital***
130 Ton, O&M
210 Ton, Capital***
210 Ton, O&M

95,000
0.075

per unit
per lb

3,500
1,000

per site
per site

220,000
0.07
346,000
0.05
390,000
0.05
500,000
0.05
460,000
0.04
495,000
0.04
595,000
0.05

per
per
per
per
per
per
per
per
per
per
per
per
per
per

unit
lb
unit
lb
unit
lb
unit
lb
unit
lb
unit
lb
unit
lb

*Consists of the time it takes to prepare and load boxes
**Consists of $60/hr for use of box van, 30 mile/hr average travel time (including
stops), and 3-ton capacity of box van
***Includes cost of shredder
****Consists of $85/hr for truck, 12-ton capacity of truck, and 42 mile/hr average
speed
*****Consists of $85/hr for truck, 12-ton capacity of truck, and 0.5 hours for
unloading
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Monthly Average Total Processing Costs per Ton of Waste
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Figure 3. Average total costs of processing biomedical wastes, by
volume of waste processed.
treatment is approximately $0.50 per pound. However, if that
hospital were to collaborate with other hospitals to buy and operate
a large machine (i.e., 100-ton-per-month capacity), the average total
cost for treatment drops to less than $0.10 per pound. Thus, there are
processing cost benefits (economies of size) to collaboration.

Disposal Costs

The last aspect of biomedical waste collection, treatment and
disposal options is the disposal of the treated waste. Historically,
Maine DEP policy has required that all biomedical wastes be
unrecognizable. Shredding the waste to make it unrecognizable
provides an indication that the waste has been treated and reduces
the potential for anxiety over the presence of intact biomedical waste
in public landfills. After shredding, the treated waste is shipped to
any of six landfills in the state that have been included in the model
as hypothetical disposal locations. The cost for disposal consists of
the hauling cost from the treatment site to the landfill, the cost of
transferring the waste at the landfill, and the per-ton tipping fee at
the landfill.
The hauling cost is calculated using estimates of the cost and the
capacity of the hauling trucks as well as a travel-time estimate
between hospitals and landfills. The cost of transferring the waste at
the landfill consists of the estimated time it takes to dump the waste
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multiplied by the hourly cost of the truck. The per-ton tipping fee is
based on rates published by each landfill.
In addition to the least-cost scenarios described earlier, this
project also estimates the cost of biomedical waste disposal for each
hospital under the current approach of shipping all waste out of
state. Using recorded costs per ton of waste for various hospitals, a
linear regression model was used to estimate costs per ton for each
hospital in the state.
Based on the cost information noted above, the model evaluates
the total cost of all the possible permutations of the collection,
treatment, and disposal of all hospital-generated biomedical waste in
Maine and selects the least-cost option2 . In doing so, the model
determines the size of treatment equipment to use, how many pieces
of each size of treatment equipment to use, at which hospital(s) the
treatment equipment will be located, the optimal disposal site(s) for
the treated waste, and which hospitals, if any, should continue to
ship their waste out of state.

RESULTS
The model solution identifies significant cost savings compared
to Maine hospitals’ current approach to biomedical waste disposal.
The model estimates the weighted average cost per ton of waste for
all Maine hospitals as a group. Some hospitals will have a lower cost
while other hospitals will have a higher cost. Currently, with all of
Maine’s biomedical waste shipped out of state, the estimated weighted
average cost for each Maine hospital is $685 per ton of waste.
In the base scenario, where all hospitals are potential waste
treatment sites, the model determines that the least-cost option
consists of two treatment machines—a very large treatment machine at Eastern Maine Medical Center (EMMC) in Bangor and a
medium-sized treatment machine at Maine Medical Center (MMC)
in Portland.
The facility in Bangor treats a total of 71 tons at an average cost
of $446 per ton. In Portland, the medium-sized facility would operate
at full capacity to treat 35 tons of waste at an average cost of $446 per
ton. Sanford and York hospitals continue to ship their waste out of
state, while Biddeford ships some of its waste to Portland and some
out of state. For this solution, the weighted average cost for all
Maine hospitals is $445 per ton of waste (see Figure 4).
2
The model was constructed with the spreadsheet optimization program
What’sBest!, version 5.0, from LINDO Systems, Inc. The model includes 2,106
variables (156 integer variables) and 468 linear constraints. The base scenario
required 1.9 million iterations to generate a solution.
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Medical Waste Management Mode
Base Scenario

Figure 4. Model results under assumptions of the base scenario.
In the big four scenario, the four larger hospitals (MMC in
Portland, EMMC in Bangor, and Maine General Medical Center and
Inland Hospitals in Waterville) are evaluated individually while the
least-cost solution for the remaining 35 hospitals is determined for
those hospitals as group. In this scenario, EMMC processes its own
waste on-site with a medium-sized machine. The Waterville hospitals and MMC in Portland continue to ship their waste out of state.
To process the waste generated by the remaining hospitals, the
model situates one very large treatment machine at Central Maine
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Medical Center (CMMC) in Lewiston, while York continues to ship
its waste out of state. The facility in Lewiston processes a total of 63
tons of waste at an average cost of $516 per ton. The weighted
average cost for all Maine hospitals under this scenario, including
the four larger hospitals, is $518 per ton of waste (see Figure 5).
The capital cost of a shredder is a significant proportion of the
equipment costs. As a result, the no-shred scenario produces substantially different results. By removing the shredding requirement,
the capital costs are reduced, but the boxing and transporting costs
are relatively more expensive. Thus, it becomes cost effective to
operate a larger number of small and medium machines across the

Figure 5. Model results under assumptions of the big four scenario.
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state to treat the non-sharps portion of the waste stream. Under this
scenario, there are eight small machines scattered around the state
and two medium machines—one each at EMMC in Bangor and at
MMC in Portland. The sharps are treated and shredded with a single
machine located at EMMC in Bangor.
The weighted average cost of treating the non-sharps biomedical
wastes (i.e., 95% of the biomedical waste stream) without shredding
is $391 per ton. The cost to treat and shred the sharps (i.e., 5% of the
biomedical waste stream) separately is $817 per ton. The combined
total to treat all of the biomedical waste under this scenario is $412
per ton (see Figure 6).

Figure 6. Model results under assumptions of the no shred scenario.
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CONCLUSIONS
These results are only applicable where Maine hospitals are
willing to collaborate with regards to biomedical waste disposal
options. As the model has shown, it may still be cost effective for
some hospitals to ship out of state. However, concerns over future
availability and potential cost increases associated with out-of-state
options may also lead those hospitals to collaborate. Each of the
scenarios examined in this study involved some degree of collaboration that resulted in overall cost savings compared to the current
situation (see Figure 7).
For any actions considered by hospitals with regards to the
collection, treatment and disposal of biomedical wastes there are a
number of key findings of this project that are significant. First, instate collection, treatment, and disposal can provide overall cost
savings, as shown by the decrease in average weighted costs in all
three of the alternative scenarios. Second, while treatment costs are
an integral part of the total cost of collection, treatment, and disposal
of biomedical waste in Maine, the handling costs are also significant.
Savings are likely to be realized by collaborating on everything from
box and bag purchasing to shipping of untreated waste. Third, capital
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Figure 7. Weighted average statewide cost per ton for treating
biomedical waste in Maine under different scenarios.
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requirements of shredding are not cost effective for smaller hospitals. As shown in the first two scenarios, waste treatment with
shredding is only processed at the larger hospitals; it is not until the
shredding requirement is removed that on-site waste treatment
becomes cost effective for smaller hospitals. And fourth, cost savings
with in-state collection, treatment, and disposal of biomedical waste
will vary from hospital to hospital depending upon the location of the
hospital and its particular situation.

RECOMMENDATIONS
The results presented in this analysis are a significant contribution to the on-going evaluation of biomedical waste collection,
treatment, and disposal in Maine. However, in order to reach a
specific solution, more research is needed. The following three
components are recommended: (1) evaluate alternative handling
technologies; (2) examine specific treatment technologies; and (3)
explore on-site versus off-site location issues and off-site treatment
analysis.
Regarding the first component, an inquiry into lower-cost handling technologies should be made. For example, current boxing of
untreated waste in cardboard boxes is an expensive approach that
raises logistical issues. In place of cardboard boxes, perhaps biomedical waste could be transported in large, reusable, rolling tubs with
water-tight lids. This seems a logical approach, but more research is
needed to determine if the approach warrants serious consideration.
With regard to the second component, an examination of the
specific treatment technologies is needed. The current analysis uses
estimated costs of two technologies, and makes no claims regarding
the specific technologies themselves. For hospitals to make appropriate choices, the advantages and disadvantages of each treatment
technology must be known. Some of this work has been completed
by Maine Department of Environmental Protection staff, but the
final decisions must be made by the purchasers of the equipment.
Contact with hospital staff where these two technologies are currently being used is strongly recommended.
This analysis assumes that the waste-treatment facilities will be
located at various hospitals. While this assumption works in this
analysis, it may be problematic in actual practice. First, hospitals
may not have the physical space for an on-site waste treatment
facility. Many hospitals use all the physical space available and have
no space for a waste-treatment facility. Second, while hospitals may
have the physical space to build a waste-treatment facility, they may
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not want to incur legal, logistical, and public relations problems
associated with a treatment facility on hospital grounds.
As a result of these impediments to locating a waste-treatment
facility on hospital grounds, it is recommended that the results of
this current analysis be extended by incorporating the additional
costs associated with development of an off-site location for a wastetreatment facility. The determination of those added costs would be
accomplished by including engineering and site development costs
into the analysis. By developing such a scenario(s), hospitals are
relieved of housing a waste-treatment facility on-site and the added
responsibilities that go with that facility. In addition, an off-site
location presents a more balanced opportunity for hospital-tohospital collaboration. No matter the scenario, however, it is
estimated that there will have to be some degree of hospital-tohospital collaboration in order to achieve the least-cost results.
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